Microtubule抑制剂;甲基澳瑞他汀E(MMAE);MICROTUBULE抑制剂;MMAE,(VEDOTIN)一甲基澳瑞他汀E;MMAE单(4-羟基苯基)琥珀酸;一甲基澳瑞他汀E;MMAE,(Vedotin)一甲基澳瑞他汀E;Microtubule抑制剂;一甲基奥瑞他汀E

[3H]-Vedotin; MonoMethyl auristatin E;MonoMethylauristatinE(MMAE,vedotin);HM-297C-22;MonoMethylauristatinE;MMAE;Vedotin;N-Methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamideMonomethyl;MonomethylauristatinE,>=98%;(S)-N-((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1R,2R)-1-Hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxohe